Please see the latest Wormser publication below downplaying another spirochetal tick bone infection which we have yet to study in any great detail.

The attached picture is The American Journal of Medicine’s Editor-in-Chief, Joseph Alpert, MD found at the following link:

http://deptmedicine.arizona.edu/profile/joseph-s-alpert-md

 ------ Original Message ----------
From: Carl Tuttle <runagain@comcast.net>
To: jaucott2@jhmi.edu, tickbornedisease@hhs.gov
Cc: Anthony.Fauci@nih.hhs.gov
Date: August 27, 2018 at 1:25 PM
Subject: Borrelia Miyamotoi: An Emerging Tick-Borne Pathogen

To the TBD Working Group,

Please see the latest Wormser publication referencing Borrelia Miyamotoi:

Wormser statement:

Active infection is most appropriately diagnosed by a validated polymerase chain reaction (PCR) assay on a blood sample targeting a specific B. miyamotoi gene segment.

(My Response) DNA Sequencing for Lyme however is not allowed.

Borrelia Miyamotoi: An Emerging Tick-Borne Pathogen
Gary P. Wormser M.D. , Eugene D. Shapiro M.D. ,Durland Fish Ph.D.
https://www.amjmed.com/article/S0002-9343(18)30796-4/fulltext

Excerpt #1

1. Unlike with Lyme disease, there are no United States Food and Drug Administration approved diagnostic tests for B. miyamotoi infection. However, given the infrequency with which B. miyamotoi infections have been recognized in the United States, it would not be surprising if a substantial proportion of infections are minimally symptomatic or asymptomatic and are self-resolving.

(My Response) If there is no laboratory test available to detect this pathogen how could it be recognized???

(My Response) Self-resolving??? This statement is based on one single patient experience reported in 2016 from the Wormser paper below:

Insights into Borrelia miyamotoi infection from an untreated case demonstrating relapsing fever, monocytosis and a positive C6 Lyme serology.
https://www.ncbi.nlm.nih.gov/pubmed/27412815

(My Response) What happens when B. miyamotoi is transmitted along with all the toxic soup (co-infections) carried by these ticks?

Excerpt #2

The same antibiotic regimens used to treat Lyme disease (e.g., 10-14 day courses of oral doxycycline or amoxicillin) are effective for B. miyamotoi infection, although parenteral therapy with ceftriaxone would be preferred for infected patients with chronic meningitis.

(My Response) Chronic meningitis??? So then Borrelia miyamotoi infection can become chronic??? 

(My Response) B. miyamotoi is the only species of Borrelia capable of causing chronic infection???

(My Response) What is the consequence of untreated Borrelia miyamotoi infection of months, years or decades as experienced by the disabled Lyme patient community?

(My Response) Anyone following the years of propaganda produced by Wormser and his fellow racketeering cohorts will clearly recognize an immediate downplaying of this Tick Borne Disease before the infection is studied in great detail.
Just like Lyme disease…. no big deal! (Racketeering 101 financed by the National Institutes of Health) You are now CME qualified to ignore yet another spirochetal infection.
As for the insurance companies; it’s ok to deny claims to treat Borrelia miyamotoi infection beyond the 10-14 days as mentioned in this publication. Gary will be available as an "Expert Witness" to protect your bottom line.

Today's propaganda was brought to you by: The American Journal of Medicine

Sincerely,

Carl Tuttle
Lyme Endemic Hudson, NH

Cc: Attorney Daniel Dutko of Hanszen Laporte

Representatives Chris Smith and Colin Peterson

Anthony S. Fauci, M.D., Director, NIAID